Benjamin J. Zeskind, PRESIDENT AND CEO, 10% Owner at Immuneering Corp (IMRX), bought 3,000 shares at $8.02 ($24K) on 2022-03-23, disclosed to the SEC on 2022-03-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IMRX | BUY | 2025-06-20 | $50K | — | Filing → |
| IMRX | BUY | 2024-03-19 | $55K | — | Filing → |
| IMRX | BUY | 2021-09-14 | $48K | — | Filing → |